Phase 4 Alzheimer Disease Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Alpha Cognition, Inc150 enrolled1 locationNCT07633470
Recruiting
Phase 4
Aβ Dynamics in LLMD
Alzheimer DiseaseMajor Depressive Disorder
NYU Langone Health60 enrolled2 locationsNCT05004987
Recruiting
Phase 4
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
SleepAlzheimer DiseaseInsomnia Disorder
University Hospital, Montpellier62 enrolled1 locationNCT05924425
Recruiting
Phase 4
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
Alzheimer Disease
Mayo Clinic614 enrolled2 locationsNCT03821857
Recruiting
Phase 4
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Daewoong Bio Inc.630 enrolled4 locationsNCT05383183
Recruiting
Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Alzheimer Disease
University of Texas at Austin156 enrolled1 locationNCT03082755